| Product NDC: | 42582-200 |
| Proprietary Name: | ISOXSUPRINE HYDROCHLORIDE |
| Non Proprietary Name: | isoxsuprine hydrochloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; isoxsuprine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42582-200 |
| Labeler Name: | Bi-Coastal Pharmaceutical Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20110602 |
| Package NDC: | 42582-200-20 |
| Package Description: | 1000 TABLET in 1 BOTTLE (42582-200-20) |
| NDC Code | 42582-200-20 |
| Proprietary Name | ISOXSUPRINE HYDROCHLORIDE |
| Package Description | 1000 TABLET in 1 BOTTLE (42582-200-20) |
| Product NDC | 42582-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | isoxsuprine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110602 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Bi-Coastal Pharmaceutical Corporation |
| Substance Name | ISOXSUPRINE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |